Pierre Haen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Pierre Haen has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Christophe Dubois
Affiliations Aix Marseille University, INRAE 1260 (Institut National de la Recherche Agronomique et de l’Environnement), INSERM 1263 (Institut National de la Santé et de la Recherche), C2VN (Center for CardioVascular and Nutrition Research), Marseille, France, Marseille University, PIVMI (Plateforme d’Imagerie Vasculaire et de Microscopie Intravitale), C2VN (Center for CardioVascular and Nutrition Research), Marseille, France
2 shared publications - Diane Mege
Department of Digestive Surgery, Aix Marseille Univ, APHM, Timone University Hospital, Marseille, France
2 shared publications - Laurence Panicot-Dubois
Aix-Marseille Univ, INSERM 1263, INRAE 1062, C2VN, 13385 Marseille, France
2 shared publications - Lydie Crescence
Aix Marseille University, INSERM 1263 (Institut National de la Santé et de la Recherche), INRAE 1260 (Institut National de la Recherche Agronomique et de l’Environnement), C2VN (Center for CardioVascular and Nutrition Research), 13885 Marseille, France
2 shared publications Thomas Schouman
Service de chirurgie maxillofaciale et stomatologie, Hôpital Universitaire Pitié-Salpêtrière, Assistance Publique - Hôpitaux de Paris, Faculté de médecine, Sorbonne Université; Paris, France
2 shared publications- Alexandre Altié
Aix Marseille Université, INSERM 1263, INRAE, C2VN, 13885 Marseille, France
1 shared publication
Latest Publications
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Le risque thrombotique associé aux cancers de la tête et du cou : étude d'un modèle de carcinome épidermoïde de la langue chez la souris
La maladie thromboembolique veineuse est la seconde cause de mortalité chez le patient atteint d’un cancer. Le risque thrombotique associé au cancer varie selon les caractéristiques de la pathologie tumorale : localisation, forme histologique, stade, type de traitement. Les cancers de la cavité buccale sont les plus fréquents des cancers de la tête et du cou et la forme histologique la plus fréquente est le carcinome épidermoïde (CE). Le risque thrombotique associé aux carcinomes épidermoïdes de la cavité buccale est considéré comme très bas, voire inexistant. Cependant de nombreuses études ont rapporté que les carcinomes épidermoïdes de la cavité buccale présentaient toutes les caractéristiques biologiques d’un cancer à haut risque thrombotique.En utilisant un modèle de carcinome épidermoïde de la langue (CEL) chez la souris, notre étude avait pour but de clarifier cette situation paradoxale. Notre étude a d’abord montré que les cellules de CEL présentaient effectivement un profil pro-thrombotique, avec une élévation du risque thrombotique « local »,mais qu’il n’existait pas d’élévation du risque thrombotique « à distance » chez les souris avec un CEL, avec même une diminution de ce risque. Notre étude a ensuite montré qu’il existait une diminution de la réactivité plaquettaire chez les souris avec un CEL expliquantcette diminution du risque thrombotique systémique. Enfin, nous avons montré que les souris avec un CEL présentaient une diminution du nombre de granule delta plaquettaire responsable de cette hypo-réactivité des plaquettes et du faible risque thrombotique systémique associé.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Le risque thrombotique associé aux cancers de la tête et du cou : étude d'un modèle de carcinome épidermoïde de la langue chez la souris
La maladie thromboembolique veineuse est la seconde cause de mortalité chez le patient atteint d’un cancer. Le risque thrombotique associé au cancer varie selon les caractéristiques de la pathologie tumorale : localisation, forme histologique, stade, type de traitement. Les cancers de la cavité buccale sont les plus fréquents des cancers de la tête et du cou et la forme histologique la plus fréquente est le carcinome épidermoïde (CE). Le risque thrombotique associé aux carcinomes épidermoïdes de la cavité buccale est considéré comme très bas, voire inexistant. Cependant de nombreuses études ont rapporté que les carcinomes épidermoïdes de la cavité buccale présentaient toutes les caractéristiques biologiques d’un cancer à haut risque thrombotique.En utilisant un modèle de carcinome épidermoïde de la langue (CEL) chez la souris, notre étude avait pour but de clarifier cette situation paradoxale. Notre étude a d’abord montré que les cellules de CEL présentaient effectivement un profil pro-thrombotique, avec une élévation du risque thrombotique « local »,mais qu’il n’existait pas d’élévation du risque thrombotique « à distance » chez les souris avec un CEL, avec même une diminution de ce risque. Notre étude a ensuite montré qu’il existait une diminution de la réactivité plaquettaire chez les souris avec un CEL expliquantcette diminution du risque thrombotique systémique. Enfin, nous avons montré que les souris avec un CEL présentaient une diminution du nombre de granule delta plaquettaire responsable de cette hypo-réactivité des plaquettes et du faible risque thrombotique systémique associé.
- Open Access
- 24 February 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (3) , 228
Oral Squamous Cell Carcinoma Is Associated with a Low Thrombosis Risk Due to Storage Pool Deficiency in Platelets
Venous thrombo-embolism (VTE) disease is the second most common cause of mortality in cancer patients, and evaluation and prevention of thrombosis risk is essential. VTE-associated risk varies according to the type of tumor disease. Oral cancer is the most frequent type of head and neck cancer, and it represents approximately 2.1% of all cancers worldwide. Most tumors are squamous cell carcinomas and are mainly due to tobacco and alcohol abuse. VTE risk associated with oral squamous cell carcinoma (OSCC) is low. However, many studies have shown that OSCC has the following biological features of cancers associated with a high thrombosis risk: modified thrombosis and fibrinolysis mechanisms; strong expression of procoagulant proteins; secretion of procoagulant microparticles; and production of procoagulant cytokines. Using an original mouse model of tongue squamous cell carcinoma, our study aimed to clarify this paradoxical situation. First, we showed that OSCC tumors have a pro-aggregatory phenotype and a high local thrombosis risk. Second, we found that tongue tumor mice do not have an elevated systemic thrombosis risk (the risk of an “at distance” thrombosis event such as lower extremity deep venous thrombosis or pulmonary embolism) and even show a reduction in risk. Third, we demonstrated that tongue tumor mice show a reduction in platelet reactivity, which explains the low systemic thrombosis risk. Finally, we found that tongue tumor mice present granule pool deficiency, thereby explaining the reduction in platelet reactivity and systemic thrombosis risk.
- 24 February 2021
- Published by MDPI AG in Biomedicines
- Vol. 9 (3) , 228
Open AccessOral Squamous Cell Carcinoma Is Associated with a Low Thrombosis Risk Due to Storage Pool Deficiency in Platelets
Venous thrombo-embolism (VTE) disease is the second most common cause of mortality in cancer patients, and evaluation and prevention of thrombosis risk is essential. VTE-associated risk varies according to the type of tumor disease. Oral cancer is the most frequent type of head and neck cancer, and it represents approximately 2.1% of all cancers worldwide. Most tumors are squamous cell carcinomas and are mainly due to tobacco and alcohol abuse. VTE risk associated with oral squamous cell carcinoma (OSCC) is low. However, many studies have shown that OSCC has the following biological features of cancers associated with a high thrombosis risk: modified thrombosis and fibrinolysis mechanisms; strong expression of procoagulant proteins; secretion of procoagulant microparticles; and production of procoagulant cytokines. Using an original mouse model of tongue squamous cell carcinoma, our study aimed to clarify this paradoxical situation. First, we showed that OSCC tumors have a pro-aggregatory phenotype and a high local thrombosis risk. Second, we found that tongue tumor mice do not have an elevated systemic thrombosis risk (the risk of an “at distance” thrombosis event such as lower extremity deep venous thrombosis or pulmonary embolism) and even show a reduction in risk. Third, we demonstrated that tongue tumor mice show a reduction in platelet reactivity, which explains the low systemic thrombosis risk. Finally, we found that tongue tumor mice present granule pool deficiency, thereby explaining the reduction in platelet reactivity and systemic thrombosis risk.
- 1 June 2020
- Published by Elsevier in Oral Oncology
- Vol. 105, 104729
CORONA-steps for tracheotomy in COVID-19 patients: A staff-safe method for airway management
- 1 June 2020
- Published by Elsevier in Oral Oncology
- Vol. 105, 104729
CORONA-steps for tracheotomy in COVID-19 patients: A staff-safe method for airway management
- Open Access
- 11 June 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (11) , 2838
Thrombosis Risk Associated with Head and Neck Cancer: A Review
Venous thromboembolism (VTE) is a common complication for cancer patients. VTE-associated risk varies according to the type of tumor disease. Head and neck cancer is a common cancer worldwide, and most tumors are squamous cell carcinomas due to tobacco and alcohol abuse. The risk of VTE associated with head and neck (H&N) cancer is considered empirically low, but despite the high incidence of H&N cancer, few data are available on this cancer; thus, it is difficult to state the risk of VTE. Our review aims to clarify this situation and tries to assess the real VTE risk associated with H&N cancer. We report that most clinical studies have concluded that there is a very low thrombosis risk associated with H&N cancer. Even with the biases that often exist, this clinical review seems to confirm that the risk of VTE was empirically hypothesized. Furthermore, we highlight that H&N cancer has all the biological features of a cancer associated with a high thrombosis risk, including a strong expression of procoagulant proteins, modified thrombosis/fibrinolysis mechanisms, and secretions of procoagulant microparticles and procoagulant cytokines. Thus, this is a paradoxical situation, and some undiscovered mechanisms that could explain this clinical biological ambivalence might exist.
- 11 June 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (11) , 2838
Open AccessThrombosis Risk Associated with Head and Neck Cancer: A Review
Venous thromboembolism (VTE) is a common complication for cancer patients. VTE-associated risk varies according to the type of tumor disease. Head and neck cancer is a common cancer worldwide, and most tumors are squamous cell carcinomas due to tobacco and alcohol abuse. The risk of VTE associated with head and neck (H&N) cancer is considered empirically low, but despite the high incidence of H&N cancer, few data are available on this cancer; thus, it is difficult to state the risk of VTE. Our review aims to clarify this situation and tries to assess the real VTE risk associated with H&N cancer. We report that most clinical studies have concluded that there is a very low thrombosis risk associated with H&N cancer. Even with the biases that often exist, this clinical review seems to confirm that the risk of VTE was empirically hypothesized. Furthermore, we highlight that H&N cancer has all the biological features of a cancer associated with a high thrombosis risk, including a strong expression of procoagulant proteins, modified thrombosis/fibrinolysis mechanisms, and secretions of procoagulant microparticles and procoagulant cytokines. Thus, this is a paradoxical situation, and some undiscovered mechanisms that could explain this clinical biological ambivalence might exist.
- 1 April 2019
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 120 (2) , 91-94
Finite element analysis of the human orbit. Behavior of titanium mesh for orbital floor reconstruction in case of trauma recurrence
- 1 April 2019
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 120 (2) , 91-94
Finite element analysis of the human orbit. Behavior of titanium mesh for orbital floor reconstruction in case of trauma recurrence
- 1 February 2018
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 46 (2) , 329-337
Comparative finite element analysis of skull mechanical properties following parietal bone graft harvesting in adults
- 1 February 2018
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 46 (2) , 329-337
Comparative finite element analysis of skull mechanical properties following parietal bone graft harvesting in adults
- 1 February 2017
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 118 (1) , 63-65
Necrotizing sialometaplasia of the parotid gland associated with facial nerve paralysis
- 1 February 2017
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 118 (1) , 63-65
Necrotizing sialometaplasia of the parotid gland associated with facial nerve paralysis
- 1 November 2014
- Published by Elsevier in Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale
- Vol. 115 (5) , 265-267
Chirurgie post-implantaire ou les trois coups
- 1 November 2014
- Published by Elsevier in Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale
- Vol. 115 (5) , 265-267
Chirurgie post-implantaire ou les trois coups
- 30 June 2009
- Published by Elsevier in Revue de Stomatologie et de Chirurgie Maxillo-faciale
- Vol. 110 (3) , 155-157
Foyers d’hématopoïèse intramandibulaire. Une pathologie méconnue
- 30 June 2009
- Published by Elsevier in Revue de Stomatologie et de Chirurgie Maxillo-faciale
- Vol. 110 (3) , 155-157
Foyers d’hématopoïèse intramandibulaire. Une pathologie méconnue